Search results
J&J (JNJ) Seeks Full FDA Nod for Balversa in Urothelial Cancer
Zacks via Yahoo Finance· 9 months agoJohnson & Johnson JNJ announced that it has submitted a supplemental new drug application (sNDA) to...
Incyte (INCY) Gets FDA Nod for Label Expansion of Pemazyre
Zacks via Yahoo Finance· 2 years agoIncyte (INCY) obtains FDA approval for Pemazyre for a second indication - the treatment of adults...
Incyte (INCY) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoIncyte Corporation INCY is scheduled to release its fourth-quarter and full-year 2022 results on Feb...
Incyte's (INCY) Pemazyre Gets Approval to Treat MLNs in Japan
Zacks via Yahoo Finance· 1 year agoIncyte INCY announced that it has received approval for treating patients with myeloid or lymphoid...
Personalised drug therapy hope for bile duct cancer patients
Press Association News via AOL· 1 year agoA drug treatment for bile duct cancer patients with a rare mutation has been shown to improve...
Incyte's (INCY) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoIncyte's (INCY) earnings and revenues fall shy of estimates in the third quarter of 2022. The...